Translational Research Cancer Center Consortium Inc
Public records show a registered, tax-exempt organization in good standing.
What it says it does
Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists.
- Income
- $239,968
- Spending
- $121,759
- Spent on programs
- 88%
- Reserves
- 20.7 months of spending
- Largest source of income
- fees for its services, 100%
- Employees
- 0
- Volunteers
- 30
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 100 out of 100. Higher than 82% of charities in its peer group (diseases, under $250k).
Reserves
35 of 35Spendable reserves would cover 20.7 months of spending.
Debt
20 of 20It owes 2% of what it owns.
Living within its means
15 of 15Income exceeded spending by 49% of income.
Spending floor
15 of 1588% of spending went to programs.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Good: 81 out of 100. Higher than 69% of charities in its peer group (diseases, under $250k).
Independent board
25 of 2527 of 27 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
0 of 8Reports no written whistleblower policy.
Record keeping policy
0 of 7Reports no written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (2)
- $107,160 spent. The annual TRCCC meeting provides a unique opportunity for trainees to present and interact in a supportive environment, enhancing their learning experience, skills as medical professionals, and ability to push boudaries in the medical field. The 2024 Meeting was entitled Pushing Immunotherapeutic Boundaries, and consisted of numerous guest speakers from leaders within the immunotherapeutic field and provided atendees with a spatial transcriptomics workshop to learn innovative techniques on current spatial transcriptomics platforms and data analsysis, as well as learn about related emerging technologies. Other topics included, but are not limited to: the impact of the tumor microenvironment on anti-tumor immunity, novel targeting of the immune response in cancer and a discussion of gender in science and academia.
- The TRCCC is composed of Cancer Centers, or Academic Institutions with a major focus on cancer research, within an easily accessible distance to the yearly meeting site that advances the dissemination of research and new clinical trials towards the prevention, treatment and cure of cancer, with an emphasis on the study of Immuno-Oncology, immunotherapy and other biological therapies of cancer. Each member institution may choose up to two faculty members to provide their current research in platform presentations, and to have their trainees present short talks and/or posters, at the yearly meeting. Each member institution also can have their Center participate in any clinical trials that are developed at TRC3 centers and other types of inter-institutional scientific collaborations and training opportunities, such as joint NIH training grants, NCI SPORES and P01s.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since February 2021.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.